No Data
No Data
Digital Therapeutics - Global and Regional Market Size & Share Analysis With Competitive Strategies and Forecasts (2024-2032) Featuring Pear Therapeutics, Omada Health, Akili Interactive
Akili Gets FDA Clearance for ADHD Video Game Over-the-Counter Treatment
By Sabela Ojea Akili said that EndeavorOTC has been authorized by the Food and Drug Administration as an over-the-counter treatment for adults with attention-deficit/hyperactivity disorder through a
Akili Says EndeavorOTC Is The Only FDA-Authorized Digital Therapeutic For ADHD Available Without A Prescription
Delivered through an engaging video game experience, EndeavorOTC is indicated to improve attention function as measured by computer-based testing in men and women with primarily inattentive or combine
Akili Reports FDA Clearance Of EndeavorOTC (AKL-T01) As An Over-the-counter Treatment For Adults With Attention-deficit/Hyperactivity Disorder
Akili Reports FDA Clearance Of EndeavorOTC (AKL-T01) As An Over-the-counter Treatment For Adults With Attention-deficit/Hyperactivity Disorder
Express News | Akili Announces FDA Authorization of Endeavorotc, the First FDA Clearance of a Digital Treatment for Adults With Adhd Through a Video Game
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Akili, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - June 4, 2024) - Rigrodsky Law, P.A. is investigating Akili, Inc. ("Akili") (NASDAQ: AKLI) regarding possible breaches of fiduciary duties and other violations o